Youll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation, and understanding of scientific data. This means youll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the aging immune system and immunotherapy; natural killer cells/tumor-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.
At least a lower second (2.2) UK first degree (or equivalent) in an appropriate subject, for example, pharmacology, biomedical science, biological science, or medical genetics (these will be considered on an individual basis).
The overall academic IELTS score required: 6.0_x000D_ Component scores required: Listening: 5.5, Reading: 5.5,Writing: 5.5, Speaking: 5.5.
Biological and Medical Sciences
Holloway
Postgraduate
1
January, September
5.5
£13,750,
Glasgow, Scotland
6.5
27930
Newark (Main Campus), Wilmington, Lewes
$ 14000
London, England
£ UK: £9250, International/EU:£16,500
BHE UNI - Search